Anti-tumour response despite loss of donor chimaerism in patients treated with non-myeloablative conditioning and allogeneic stem cell transplantation-Reference-Cited by-同舟云学术

Anti-tumour response despite loss of donor chimaerism in patients treated with non-myeloablative conditioning and allogeneic stem cell transplantation

Published:2005-02 Issue:3 Volume:128 Page:351-359
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Dey Bimalangshu R.,McAfee Steven,Colby Christine,Cieply Kathy,Caron Martin,Saidman Susan,Preffer Frederic,Shaffer Juanita,Tarbell Nancy,Sackstein Robert,Sachs David,Sykes Megan,Spitzer Thomas R.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2004.05328.x/fullpdf

Reference25 articles.

1. Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy

2. Treatment of Murine Leukaemia with X Rays and Homologous Bone Marrow

3. Graft versus Leukemia: Quantification of Adoptive Immunotherapy in Murine Leukemia

4. Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous hematopoietic recovery after allogeneic hematopoietic stem cell transplantation: A case-based review;Transplant Immunology;2023-12

2. Immunotherapy for neuroblastoma by hematopoietic cell transplantation and post-transplant immunomodulation;Critical Reviews in Oncology/Hematology;2023-05

3. Chimerism, the Microenvironment and Control of Leukemia;Frontiers in Immunology;2021-04-22

4. Decitabine With or Without Micro-Transplantation for the Treatment of Intermediate or High-Risk Myelodysplastic Syndrome: A Chinese Single-Center Retrospective Study of 22 Patients;Frontiers in Oncology;2021-03-31

5. Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies;Frontiers in Immunology;2020-10-08